Visa Shortage Highlights Low Pay for Postdocs

LIMBO: A postdoc in Deborah Andrew's lab at Johns Hopkins School of Medicine faces an uncertain future because H-1B visas ran out before she could obtain one. During a three-year stay on a training visa, a Portuguese postdoc in Deborah Andrew's lab at Johns Hopkins School of Medicine began characterizing titin --a gene that codes for a key muscle protein. She may not get to finish. The reason? Her training visa's extension ran out last month. And her efforts to apply for the five-year H-1B

Written byPaul Smaglik
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


LIMBO: A postdoc in Deborah Andrew's lab at Johns Hopkins School of Medicine faces an uncertain future because H-1B visas ran out before she could obtain one.
During a three-year stay on a training visa, a Portuguese postdoc in Deborah Andrew's lab at Johns Hopkins School of Medicine began characterizing titin --a gene that codes for a key muscle protein. She may not get to finish.

The reason? Her training visa's extension ran out last month. And her efforts to apply for the five-year H-1B visa have been thwarted. The capped limit on the 65,000 visas for temporary professionals was met May 11--months before the first-come, first-served visa again becomes available at the start of the fiscal year Oct. 1.

Congress is in the midst of increasing the availability of the visas. The Senate has already voted to boost them by 30,000 for the rest of this year. The House ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies